Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.10% | -15.28% | 4.68% | -2.54% | 4.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.10% | -15.28% | 4.68% | -2.54% | 4.14% |
| Cost of Revenue | -2.01% | 0.29% | -5.80% | -10.51% | -17.25% |
| Gross Profit | 26.24% | -32.81% | 28.77% | 17.51% | 94.26% |
| SG&A Expenses | -19.73% | 8.73% | 4.20% | -4.41% | 28.50% |
| Depreciation & Amortization | 1.74% | 1.84% | 1.43% | 1.12% | -2.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.92% | 5.15% | 2.60% | -5.18% | 3.37% |
| Operating Income | 47.76% | -8,080.84% | 4.51% | 12.19% | -1.68% |
| Income Before Tax | 94.46% | -370.15% | 23.71% | 32.67% | -333.91% |
| Income Tax Expenses | 82.92% | -118.88% | 31.70% | 93.71% | -15.73% |
| Earnings from Continuing Operations | 95.39% | -9.12% | 21.57% | 12.64% | -457.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -95.12% | -87.19% | 5.26% | -24.56% | 2,434.84% |
| Net Income | 95.41% | -11.76% | 22.43% | 12.24% | -437.72% |
| EBIT | 47.76% | -8,080.84% | 4.51% | 12.19% | -1.68% |
| EBITDA | 59.17% | -268.23% | 5.44% | 15.66% | -18.36% |
| EPS Basic | 95.54% | -10.28% | 23.15% | 12.94% | -435.05% |
| Normalized Basic EPS | 51.25% | -211.30% | 25.63% | 33.51% | 46.87% |
| EPS Diluted | 95.52% | -9.45% | 23.68% | 13.04% | -431.49% |
| Normalized Diluted EPS | 51.25% | -211.30% | 25.63% | 33.51% | 46.87% |
| Average Basic Shares Outstanding | 2.96% | 1.34% | 0.96% | 0.79% | 0.49% |
| Average Diluted Shares Outstanding | 2.96% | 1.34% | 0.96% | 0.79% | 0.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
